Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013390 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Treatment Methods for Clinically Significant Tinnitus
A Phase 2 study of Tinnitus, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00013390: Completed Phase 2 study of Tinnitus, sponsored by US Department of Veterans Affairs.
NCT00013390 is a Phase 2 study of Tinnitus that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 200 participants, below the 12,611-participant average among 24 other Tinnitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013390, a Phase 2 study of Tinnitus, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospective subjects are randomly assigned to one of two treatment groups. Changes in group performance will be compared for selected measures.
Primary Outcome
A well-developed scale currently in use at the Oregon Tinnitus Clinic.
Conditions Studied
Interventions
- PROCEDURE Tinnitus Masking
- PROCEDURE Tinnitus Retraining Therapy
Study Locations (1)
Oregon
- VA Medical Center, Portland - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1999-10 |
| Est. Completion | 2002-09 |
| Phase | Phase 2 |
What the finished NCT00013390 record still lists
NCT00013390 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 12,611-participant average among 24 other Tinnitus trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which Tinnitus Masking is the first listed.
NCT00013390 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00013390 about?
NCT00013390 is a clinical study titled "Evaluation of Treatment Methods for Clinically Significant Tinnitus". The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospec...
What is the current status of trial NCT00013390?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 1999-10. Estimated completion is 2002-09.
What conditions does trial NCT00013390 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT00013390?
The interventions under investigation include: Tinnitus Masking (PROCEDURE), Tinnitus Retraining Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00013390?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013390 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00013390's enrollment target sits among peer trials
200 6th of 24 higher than 19 of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
COMPLETED · Phase 2
-
Zinc to Treat Tinnitus in the Elderly
COMPLETED · Phase 2
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia